Introduction
In a significant procurement development for Qatar’s healthcare sector, Hamad Medical Corporation (HMC) has awarded a direct agreement contract to Doha Drug Store for the supply of ZN-TRIKAFTA, a critical pharmaceutical used in advanced respiratory treatments. The contract, valued at QAR 32.05 million, was officially awarded on 20 November 2025, following a two-envelope evaluation process.
Contract Overview
Tender No. 6851/2025 covers the procurement of ZN-TRIKAFTA, comprising Elexacaftor 100 mg, Tezacaftor 50 mg, Ivacaftor 75 mg (orange cap-shaped tablets), and Ivacaftor 150 mg (blue cap-shaped tablets), packaged in sets of 84. This drug combination is a high-value therapeutic used for cystic fibrosis management, highlighting Qatar’s continued investment in modern and life-saving pharmaceuticals.
The tender was issued under a direct agreement procurement model, reserved for specialised suppliers capable of meeting strict clinical and supply chain requirements.
Winning Bidder: Doha Drug Store
Doha Drug Store, registered under Commercial Registration No. 14993 | 9039, emerged as the sole technically and financially qualified bidder. The company’s proposal of QAR 32,052,787.20 was approved in full, securing the contract’s total value.
The supplier achieved a local value ratio of 13.29%, reinforcing Qatar’s ongoing strategy to strengthen local market participation in pharmaceutical distribution.
Significance of the Award
This contract underscores HMC’s commitment to ensuring continuous availability of advanced medications for patients across Qatar. The procurement of ZN-TRIKAFTA supports improved treatment outcomes for individuals requiring complex respiratory therapies and aligns with national goals for enhanced healthcare resilience and drug security.
The award also demonstrates the capability and reliability of Doha Drug Store, one of Qatar’s longstanding pharmaceutical distributors, known for supplying branded therapies and maintaining robust medical supply logistics across the region.
Technical & Financial Process
The tender followed a two-envelope system, ensuring technical compliance prior to financial evaluation. Doha Drug Store successfully passed both stages, leading to the financial opening and official award on 20 November 2025.
Conclusion
The newly awarded contract strengthens Qatar’s pharmaceutical supply chain and ensures that vital medications remain accessible within the country’s healthcare system. With execution now moving forward, HMC and Doha Drug Store are expected to coordinate logistics and delivery phases, ensuring timely distribution of ZN-TRIKAFTA. This award marks another step in Qatar’s ongoing efforts to prioritise high-quality healthcare procurement.
Latest Government Tenders and Contract Awards in Qatar - TendersOnTime
- TendersOnTime - Your trusted source for latest government tenders, RFPs, RFQs, and contract awards in Qatar
- Stay updated with the latest public procurement opportunities and tender notices in Qatar at TendersOnTime
- Find all Qatar government tenders, eProcurement updates, and contract award notices on TendersOnTime
- Explore live tenders, bids, and procurement opportunities in Qatar with TendersOnTime - The global tender portal
- TendersOnTime brings you verified tenders, procurement news, and contract awards from Qatar and worldwide
#QatarProcurement #ContractAward #TenderResults #HamadMedicalCorporation #DohaDrugStore #PharmaceuticalSupplyQatar #GovernmentContracts #HealthcareProcurement #AwardedTendersQatar #ZNTRIKAFTASupply
